Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: Humenza
Auth. number : EU/1/10/629
Active substance : Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)
ATC: Anatomical main group: J - General antiinfectives for systemic use
Therapeutic subgroup: J07 - Vaccines
Pharmacological subgroup: J07B - Viral vaccines
Chemical subgroup: J07BB - Influenza vaccines
Chemical substance: J07BB02 - influenza, purified antigen
(See WHO ATC Index)
Indication: Prophylaxis of influenza in an officially declared pandemic situation
Marketing Authorisation Holder: Sanofi Pasteur SA
2 avenue Pont Pasteur, 69007 Lyon, France
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/06/2010 Centralised - Authorisation EMEA/H/C/1202 (2010)3809 of 08/06/2010
16/06/2011 Centralised - Withdrawal (2011)4301 of 14/06/2011